A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Over-the-Counter Drugs: Making the Switch from Prescription
This bill is currently in the early stages of the legislative process. It was recently introduced in the Senate and sent to the Committee on Health, Education, Labor, and Pensions for review. There are no upcoming votes scheduled at this time.
Legislative Progress
The bill has support from both parties, which usually helps it move forward. However, it is still in the early stages of the lawmaking process and has not yet been voted on by a committee.
Key Points
- This bill creates a clearer path for drug companies to turn prescription medicines into over-the-counter products. It requires the FDA to provide better instructions and more support to companies trying to make this change.
- The FDA would be required to meet with companies to talk about safety and what kind of evidence is needed to prove a drug is safe for the general public. This includes looking at how new technology like phone apps could help people use the medicine safely without a doctor.
- The goal is to make more medicines available at local stores and potentially lower costs for families. A government watchdog would also study the process to see how many drugs are being moved to store shelves and what might be causing delays.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Data Sources
Sponsor
Cosponsors
(1)Analysis generated by AI. Always verify with official sources.